You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美股異動 | BioNTech(BNTX.US)盤前跌逾1% 遭大摩下調目標價至150美元
格隆匯 03-31 16:55
格隆匯3月31日丨BioNTech(BNTX.US)盤前跌1.4%,報120.85美元。大摩分析師Matthew Harrison將BioNTech的目標價從216美元下調至150美元,並保持對該股的持股觀望評級。BioNTech第四季度收入超過預期,但這“不是投資者關注的焦點”,因為管理層指引2023年新冠疫苗銷售額約為50億歐元,而共識預測為80億歐元。大摩降低了對該公司新冠疫苗業務的中期收入,以考慮指引和歐盟合同的重新調整,並表示隨着“新冠相關數字現在被重置”,2023年的重點可以轉移到研發生產系統。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account